These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25188740)

  • 1. Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?
    Ren G; Zhang Y; Mao X; Liu X; Mercer E; Marzec J; Ding D; Jiao Y; Qiu Q; Sun Y; Zhang B; Yeste-Velasco M; Chelala C; Berney D; Lu YJ
    OMICS; 2014 Oct; 18(10):615-24. PubMed ID: 25188740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome.
    Zhu Y; Ren S; Jing T; Cai X; Liu Y; Wang F; Zhang W; Shi X; Chen R; Shen J; Lu J; Xu C; Wang H; Wang H; Wang Y; Liu B; Li Y; Fang Z; Guo F; Qiao M; Shen D; Lu X; Gao X; Hou J; Sun Y
    Urol Oncol; 2015 Sep; 33(9):384.e9-20. PubMed ID: 26008593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation.
    Zhang Y; Gong M; Yuan H; Park HG; Frierson HF; Li H
    Cancer Discov; 2012 Jul; 2(7):598-607. PubMed ID: 22719019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC45A3-ELK4 functions as a long non-coding chimeric RNA.
    Qin F; Zhang Y; Liu J; Li H
    Cancer Lett; 2017 Sep; 404():53-61. PubMed ID: 28716526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
    Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
    Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Cancer Discov; 2012 Jul; 2(7):582-5. PubMed ID: 22787087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA.
    Qin F; Song Y; Zhang Y; Facemire L; Frierson H; Li H
    PLoS One; 2016; 11(3):e0150382. PubMed ID: 26938874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings.
    Ren S; Peng Z; Mao JH; Yu Y; Yin C; Gao X; Cui Z; Zhang J; Yi K; Xu W; Chen C; Wang F; Guo X; Lu J; Yang J; Wei M; Tian Z; Guan Y; Tang L; Xu C; Wang L; Gao X; Tian W; Wang J; Yang H; Wang J; Sun Y
    Cell Res; 2012 May; 22(5):806-21. PubMed ID: 22349460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer.
    Zhang Y; Mao XY; Liu X; Song RR; Berney D; Lu YJ; Ren G
    Int J Clin Exp Med; 2015; 8(9):15127-36. PubMed ID: 26628996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines.
    Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
    Int J Mol Med; 2011 Jul; 28(1):89-93. PubMed ID: 21491078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells.
    Lai J; Lehman ML; Dinger ME; Hendy SC; Mercer TR; Seim I; Lawrence MG; Mattick JS; Clements JA; Nelson CC
    RNA; 2010 Jun; 16(6):1156-66. PubMed ID: 20406994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel transcription-induced fusion RNAs in prostate cancer.
    Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
    Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset.
    Hernández S; Font-Tello A; Juanpere N; de Muga S; Lorenzo M; Salido M; Fumadó L; Serrano L; Cecchini L; Serrano S; Lloreta J
    Prostate; 2016 Jun; 76(9):854-65. PubMed ID: 26959281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
    Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.
    Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ
    Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.
    Perner S; Rupp NJ; Braun M; Rubin MA; Moch H; Dietel M; Wernert N; Jung K; Stephan C; Kristiansen G
    Int J Cancer; 2013 Feb; 132(4):807-12. PubMed ID: 22821757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.
    Palanisamy N; Ateeq B; Kalyana-Sundaram S; Pflueger D; Ramnarayanan K; Shankar S; Han B; Cao Q; Cao X; Suleman K; Kumar-Sinha C; Dhanasekaran SM; Chen YB; Esgueva R; Banerjee S; LaFargue CJ; Siddiqui J; Demichelis F; Moeller P; Bismar TA; Kuefer R; Fullen DR; Johnson TM; Greenson JK; Giordano TJ; Tan P; Tomlins SA; Varambally S; Rubin MA; Maher CA; Chinnaiyan AM
    Nat Med; 2010 Jul; 16(7):793-8. PubMed ID: 20526349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-transcriptome analysis reveals established and novel associations with TMPRSS2:ERG fusion in prostate cancer.
    Chow A; Amemiya Y; Sugar L; Nam R; Seth A
    Anticancer Res; 2012 Sep; 32(9):3629-41. PubMed ID: 22993300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7.
    Xiao G; Yao J; Kong D; Ye C; Chen R; Li L; Zeng T; Wang L; Zhang W; Shi X; Zhou T; Li J; Wang Y; Xu CL; Jiang J; Sun Y
    Eur Urol; 2019 Sep; 76(3):315-326. PubMed ID: 30527798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.